Cargando…
Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy
BACKGROUND: Diabetic nephropathy is a clinical diagnosis where proteinuria is present in a patient with diabetes. Early intervention can significantly improve the prognosis. However, imprecision of the currently available biomarkers have impaired effective therapies in a timely manner. Urinary N-ace...
Autores principales: | Sheira, Gehan, Noreldin, Nashwa, Tamer, Almokadem, Saad, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340101/ https://www.ncbi.nlm.nih.gov/pubmed/25717442 http://dx.doi.org/10.1186/s40200-015-0133-6 |
Ejemplares similares
-
Urinary N-acetyl-beta-D-glucosaminidase and malondialdehyde as a markers of renal damage in burned patients.
por: Kang, H. K., et al.
Publicado: (2001) -
Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
por: Liu, Xiao, et al.
Publicado: (2023) -
Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
por: Choi, Min Sun, et al.
Publicado: (2021) -
Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy
por: Lin, Zhi-Hao, et al.
Publicado: (2023) -
Combined Detection of Urinary Micro Albumin, α1-microglobulin and N-acetyl-β-D-glucosaminidase in the Early Diagnosis of Diabetic Nephropathy
por: Zhang, Xuejun, et al.
Publicado: (2017)